You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 21, June 2, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Tuberculosis/ Other Mycobacterium
 •World Health
 •Drug Therapy
 •Drug Therapy, Other
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Funding, Advances Invigorate TB Fight

Tracy Hampton, PhD

JAMA. 2004;291:2529-2530.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Long before the emergence of AIDS, SARS, and a host of other headline-grabbing infections, there was tuberculosis (TB). While the disease may have largely receded from the minds of many of those living in developed countries, this ancient scourge infects fully one third of the world's population and kills 2 million people each year, not including the 20% of HIV-infected individuals who die with active TB.

But no country is immune, as travel and immigration have brought the disease to all corners of the globe. Surveillance data show that 14 871 individuals with active TB disease live in the United States, less than half of whom are native-born (MMWR Morb Mortal Wkly Rep. 2004;53;209-214).


Tuberculosis, caused by the bacterium Mycobacterium tuberculosis, infects an estimated one third of the world's population. (Photo credit: www.sciencesource.com)

To complicate matters, the emergence of multidrug-resistant TB (MDR-TB) strains of . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.